Imfinzi/Imjudo
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Imfinzi/Imjudo in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Imfinzi/Imjudo.
34
Global Revenue Ranking
Recent articles on PMLiVE featuring Imfinzi/Imjudo
Approximately 6,600 people are diagnosed with liver cancer every year in the UK
Almost 900,000 new cases of liver cancer are diagnosed globally every year
The indications are for adults with liver and lung cancers, and chronic lymphocytic leukaemia
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology